Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2001 Jan;18(1):30-3.
doi: 10.1023/a:1026498629324.

Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report

D De Jong  1 , E G Van Hooren, N S Macklon, B M Mannaerts, B C Fauser
Affiliations
Case Reports

Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report

D De Jong et al. J Assist Reprod Genet. 2001 Jan.
No abstract available

PubMed Disclaimer

References

    1. Hoff JD, Quigley ME, Yen SS. Hormonal dynamics at midcycle: A reevaluation. J Clin Endocrinol Metab. 1983;57:792–796. - PubMed
    1. Moyle WR, Bahl OP, Marz L. Role of carbohydrate of human chorionic gonadotropin in the mechanism of hormone action. J Biol Chem. 1975;250:9163–9169. - PubMed
    1. Ditkoff EC, Cassidenti DL, Paulson RJ, Sauer MV, Paul WL, Rivier J, et al. The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women. Am J Obstet Gynecol. 1991;165:1811–1817. - PubMed
    1. Olivennes F, Alvarez S, Bouchard P, Fanchin R, Salat-Baroux J, Frydman R. The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: A dose finding study of 3 versus 2 mg. Hum Reprod. 1998;13:2411–2414. - PubMed
    1. The Ganirelix Dose-Finding Study Group A double-blind, randomized, dose-finding study to assess the efficacy of gonadotropin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon®) Hum Reprod. 1998;13:3023–3031. - PubMed

Publication types

MeSH terms